Cancer BiologybioRxivPreprint
HF-125, a first-in-class computer-modeled novel inhibitor of Tribbles 2, for therapy of enzalutamide resistant, neuroendocrine prostate cancer.
Sougata Ghosh Chowdhury, Pritam Biswas, Jitender Monga…·Jagadananda Ghosh
This paper designs HF-125, a TRIB2 inhibitor, using AI-based modeling to treat enzalutamide-resistant neuroendocrine prostate cancer.
DOI 10.64898/2026.04.27.720588